Schedule 13G ownership disclosure

KINIKSA PHARMACEUTICALS INTL

Class A Ordinary Shares, nominal value $0.000273235 per share · CUSIP: G52694109

Event date: 2025-03-28

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • TANG CAPITAL MANAGEMENT, LLC

    Shares: 2,178,609.00 · Class: 5.2%

  • KEVIN TANG

    Shares: 2,178,609.00 · Class: 5.2%

  • TANG CAPITAL PARTNERS, LP

    Shares: 1,041,271.00 · Class: 2.5%

  • TANG CAPITAL PARTNERS INTERNATIONAL, LP

    Shares: 953,337.00 · Class: 2.3%

  • TANG CAPITAL PARTNERS III, INC

    Shares: 139,379.00 · Class: 0.3%

  • TANG CAPITAL PARTNERS IV, INC

    Shares: 44,622.00 · Class: 0.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-25-005483
Form type
SCHEDULE 13G
Filer
Kiniksa Pharmaceuticals International, plc
CIK
CIK 1730430
Filed
Apr 04, 2025
Reporting period
Mar 28, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub